The acidic TME induced by tumour glycolysis can directly inhibit the cytotoxicity and proliferation of CD8+ T cells, which could actively promote immune escape and inhibit immunotherapy sensitivity [9]. The gene discussed is CD8A; the disease is neoplasm.